摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-methyl-N-((3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)-N-(3-(trifluoromethoxy)benzyl)-1H-imidazole-4-carboxamide | 1031332-83-8

中文名称
——
中文别名
——
英文名称
1-methyl-N-((3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)-N-(3-(trifluoromethoxy)benzyl)-1H-imidazole-4-carboxamide
英文别名
——
1-methyl-N-((3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)-N-(3-(trifluoromethoxy)benzyl)-1H-imidazole-4-carboxamide 化学式
CAS
1031332-83-8
化学式
C21H25F3N4O2
mdl
——
分子量
422.45
InChiKey
BPFSRDSVMKDEAX-BJWYYQGGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    30.0
  • 可旋转键数:
    5.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.52
  • 拓扑面积:
    50.6
  • 氢给体数:
    0.0
  • 氢受体数:
    5.0

反应信息

  • 作为产物:
    参考文献:
    名称:
    An octahydro-cyclopenta[c]pyrrole series of inhibitors of the type 1 glycine transporter
    摘要:
    We describe a novel series of inhibitors of the type 1 glycine transporter (GlyT1) as an approach to relieving the glutamatergic deficit that is thought to underlie schizophrenia. Synthesis and SAR follow-up of a series of octahydro-cyclopenta[c]pyrrole derivatives afforded potent in vitro inhibition of GlyT1 as well as in vivo activity in elevating CSF glycine. We also found that a 3-O(c-pentyl), 4-F substituent may serve as a surrogate for the widely used 3-trifluoromethoxy group, suggesting its application as an isostere for future medicinal chemistry studies. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.12.071
点击查看最新优质反应信息

文献信息

  • An octahydro-cyclopenta[c]pyrrole series of inhibitors of the type 1 glycine transporter
    作者:John A. Lowe、Shari L. DeNinno、Susan E. Drozda、Christopher J. Schmidt、Karen M. Ward、F. David Tingley、Mark Sanner、Don Tunucci、James Valentine
    DOI:10.1016/j.bmcl.2009.12.071
    日期:2010.2
    We describe a novel series of inhibitors of the type 1 glycine transporter (GlyT1) as an approach to relieving the glutamatergic deficit that is thought to underlie schizophrenia. Synthesis and SAR follow-up of a series of octahydro-cyclopenta[c]pyrrole derivatives afforded potent in vitro inhibition of GlyT1 as well as in vivo activity in elevating CSF glycine. We also found that a 3-O(c-pentyl), 4-F substituent may serve as a surrogate for the widely used 3-trifluoromethoxy group, suggesting its application as an isostere for future medicinal chemistry studies. (C) 2009 Elsevier Ltd. All rights reserved.
查看更多